Physician profile
Joe Fahed
NPI 1558527770
$23,552.56
in general payments reported to CMS, 2019-2025
26 companies · $2,680 in 2025
The $2,680 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,592 · 2020: $1,917 · 2021: $2,317 · 2022: $4,386 · 2023: $1,846 · 2024: $4,814 · 2025: $2,680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,036 · Travel and Lodging: $3,304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,035.94 |
| Travel and Lodging | $3,304.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,029.36 | 2019-2025 | Aveir, Confirm Rx, Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $4,020.79 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Accolade Sr, Watchman Flx |
| Medtronic, INC. | $3,123.61 | 2021-2025 | Mycarelink, Cobalt Dr Mri Surescan, Micra |
| Biosense Webster, INC. | $3,048.00 | 2019-2025 | Carto 3, Nuvision Ice Catheter |
| Biotronik INC. | $1,785.49 | 2019-2020 | |
| Medtronic Vascular, INC. | $1,425.29 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $476.39 | 2021-2023 | Optimizer |
| Elutia, INC. | $315.35 | 2019-2024 | Ecm Patch,Pouch |
| Cardiva Medical, INC. | $222.32 | 2023-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Pfizer INC. | $145.81 | 2019-2025 | |
| Amgen INC. | $141.13 | 2023-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $126.64 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $115.80 | 2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $94.77 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $92.15 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $50.50 | 2019-2022 | |
| Inspire Medical Systems, INC. | $49.77 | 2024 | Inspire |
| G Medical Diagnostic Services, INC. | $47.99 | 2019 | |
| Davol INC. | $46.19 | 2023 | Arista Ah Flexitip |
| Cvrx, INC. | $45.53 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $38.52 | 2020-2022 | |
| Altathera Pharmaceuticals LLC | $34.78 | 2022 | |
| Preventice Services, LLC | $26.08 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.18 | 2024 | Lifevest |
| Avinger INC. | $16.52 | 2020 | |
| Irhythm Technologies, INC. | $12.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joe Fahed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.